OBJECTIVES: The risk of cognitive impairment is a concern for patients with major depressive disorder receiving electroconvulsive therapy (ECT). Here, we evaluate the acute, short-term and long-term effects of ECT on tests of processing speed, executive function, memory, and attention. METHODS: Forty-four patients with major depressive disorder receiving ECT (61% right unilateral, 39% mixed right unilateral-bitemporal, left unilateral, and/or bitemporal lead placement) underwent a cognitive battery prior to ECT (T1), after 2 sessions (T2), and at the end of the index (T3). Thirty-two patients returned for a 6-month follow-up (T4). Thirty-three control subjects were assessed at 2 times approximately 4 weeks apart (C1 and C2). RESULTS: At baseline, patients showed deficits in processing speed, executive function, and memory compared with control subjects. Including depression severity and lead placement covariates, linear mixed-model analysis showed significant improvement in only processing speed between T1 and T3 and between T1 and T4 in patients. An acute decline in attention and verbal memory was observed at T2, but performance returned to baseline levels at T3. Longitudinal cognitive outcomes did not differ in patients defined as ECT responders/nonresponders. LIMITATIONS: Episodic memory was not measured, and medications were not controlled between T3 and T4. Control subjects also showed improvements in processing speed, suggesting practice effects for some measures. CONCLUSIONS: In this naturalistic ECT treatment study, results show that the initiation of ECT may transiently affect memory and executive function, but cognition is largely unaffected during and after ECT. Whereas some functions might improve, others will at least remain stable up to 6 months following the ECT index.
OBJECTIVES: The risk of cognitive impairment is a concern for patients with major depressive disorder receiving electroconvulsive therapy (ECT). Here, we evaluate the acute, short-term and long-term effects of ECT on tests of processing speed, executive function, memory, and attention. METHODS: Forty-four patients with major depressive disorder receiving ECT (61% right unilateral, 39% mixed right unilateral-bitemporal, left unilateral, and/or bitemporal lead placement) underwent a cognitive battery prior to ECT (T1), after 2 sessions (T2), and at the end of the index (T3). Thirty-two patients returned for a 6-month follow-up (T4). Thirty-three control subjects were assessed at 2 times approximately 4 weeks apart (C1 and C2). RESULTS: At baseline, patients showed deficits in processing speed, executive function, and memory compared with control subjects. Including depression severity and lead placement covariates, linear mixed-model analysis showed significant improvement in only processing speed between T1 and T3 and between T1 and T4 in patients. An acute decline in attention and verbal memory was observed at T2, but performance returned to baseline levels at T3. Longitudinal cognitive outcomes did not differ in patients defined as ECT responders/nonresponders. LIMITATIONS: Episodic memory was not measured, and medications were not controlled between T3 and T4. Control subjects also showed improvements in processing speed, suggesting practice effects for some measures. CONCLUSIONS: In this naturalistic ECT treatment study, results show that the initiation of ECT may transiently affect memory and executive function, but cognition is largely unaffected during and after ECT. Whereas some functions might improve, others will at least remain stable up to 6 months following the ECT index.
Authors: Esmée Verwijk; Hannie C Comijs; Rob M Kok; Harm-Pieter Spaans; Max L Stek; Erik J A Scherder Journal: J Affect Disord Date: 2012-05-15 Impact factor: 4.839
Authors: Harold A Sackeim; Joan Prudic; Rice Fuller; John Keilp; Philip W Lavori; Mark Olfson Journal: Neuropsychopharmacology Date: 2006-08-23 Impact factor: 7.853
Authors: H A Sackeim; J Prudic; D P Devanand; M S Nobler; S H Lisanby; S Peyser; L Fitzsimons; B J Moody; J Clark Journal: Arch Gen Psychiatry Date: 2000-05
Authors: Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand Journal: Brain Stimul Date: 2008-04 Impact factor: 8.955
Authors: Sarah H Lisanby; Shawn M McClintock; George Alexopoulos; Samuel H Bailine; Elisabeth Bernhardt; Mimi C Briggs; C Munro Cullum; Zhi-De Deng; Mary Dooley; Emma T Geduldig; Robert M Greenberg; Mustafa M Husain; Styliani Kaliora; Rebecca G Knapp; Vassilios Latoussakis; Lauren S Liebman; William V McCall; Martina Mueller; Georgios Petrides; Joan Prudic; Peter B Rosenquist; Matthew V Rudorfer; Shirlene Sampson; Abeba A Teklehaimanot; Kristen G Tobias; Richard D Weiner; Robert C Young; Charles H Kellner Journal: Am J Geriatr Psychiatry Date: 2019-10-12 Impact factor: 4.105
Authors: Victor M. Tang; Daniel M. Blumberger; Julia Dimitrova; Alanah Throop; Shawn M. McClintock; Daphne Voineskos; Jonathan Downar; Yuliya Knyahnytska; Benoit H. Mulsant; Paul B. Fitzgerald; Zafiris J. Daskalakis Journal: J Psychiatry Neurosci Date: 2020-09-01 Impact factor: 6.186
Authors: Jasper O Nuninga; René C W Mandl; Marco P Boks; Steven Bakker; Metten Somers; Sophie M Heringa; Wendy Nieuwdorp; Hans Hoogduin; René S Kahn; Peter Luijten; Iris E C Sommer Journal: Mol Psychiatry Date: 2019-03-12 Impact factor: 15.992
Authors: Amber M Leaver; Megha Vasavada; Shantanu H Joshi; Benjamin Wade; Roger P Woods; Randall Espinoza; Katherine L Narr Journal: Biol Psychiatry Date: 2018-10-05 Impact factor: 12.810
Authors: Jennifer L Kruse; Richard Olmstead; Gerhard Hellemann; Benjamin Wade; Janina Jiang; Megha M Vasavada; John O Brooks Iii; Eliza Congdon; Randall Espinoza; Katherine L Narr; Michael R Irwin Journal: Brain Behav Immun Date: 2020-05-29 Impact factor: 19.227
Authors: Christopher C Abbott; Davin Quinn; Jeremy Miller; Enstin Ye; Sulaiman Iqbal; Megan Lloyd; Thomas R Jones; Joel Upston; Zhi De Deng; Erik Erhardt; Shawn M McClintock Journal: Am J Geriatr Psychiatry Date: 2020-06-17 Impact factor: 4.105
Authors: Jennifer L Kruse; Richard Olmstead; Gerhard Hellemann; Elizabeth C Breen; Susannah J Tye; John O Brooks; Benjamin Wade; Eliza Congdon; Randall Espinoza; Katherine L Narr; Michael R Irwin Journal: J Psychiatr Res Date: 2021-06-09 Impact factor: 5.250
Authors: Ben J A Palanca; Hannah R Maybrier; Angela M Mickle; Nuri B Farber; R Edward Hogan; Emma R Trammel; J Wylie Spencer; Donald D Bohnenkamp; Troy S Wildes; ShiNung Ching; Eric Lenze; Mathias Basner; Max B Kelz; Michael S Avidan Journal: Front Psychiatry Date: 2018-05-14 Impact factor: 4.157